DELPHX ANNOUNCES CLOSING OF NON-BROKERED UNIT PRIVATE PLACEMENT

Rhea-AI Summary

DelphX Capital Markets (OTCQB: DPXCF) closed a non-brokered unit private placement issuing 4,100,000 units at C$0.05 per unit for gross proceeds of C$205,000 on Feb 25, 2026.

Each unit includes one common share and one warrant exercisable at $0.08 for two years; securities are subject to TSX Venture Exchange approval and a four-month plus one-day hold period. Net proceeds will be used for working capital and corporate overhead.

AI-generated analysis. Not financial advice.

Positive

• Gross proceeds of C$205,000 raised
• Issued 4,100,000 units at C$0.05 per unit
• Warrants exercisable at $0.08 for two years
• Proceeds allocated to working capital and overhead

Negative

• Immediate dilution from 4,100,000 new units
• Potential future dilution if warrants are exercised at $0.08
• Closing remains subject to TSXV approval
• Securities subject to a 4-month plus one-day hold period

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Toronto, ON, Feb. 25, 2026 (GLOBE NEWSWIRE) -- DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF) (“DelphX”), a leader in the development of new classes of structured products, announces that it has closed its non-brokered private placement previously announced on February 18, 2026 issuing 4,100,000 units (the “Units”) at a subscription price of C$0.05 per Unit, for gross proceeds of C$205,000 (“the Offering”). Each Unit consists of one common share (“Common Share”) and one Common Share purchase warrant (“Warrant”).  Each Warrant entitles the holder to purchase one Common Share at a price of $0.08, for a period of two years from the date of issuance.

Completion of the Offering is subject to the approval of the TSX Venture Exchange. The securities issued pursuant to the Offering will be subject to a hold period of four months plus one day from the date of issuance.

DelphX intends to use the net proceeds from the Offering in connection with working capital/corporate overhead.

About DelphX Capital Markets Inc.

DelphX is a technology and financial services company focused on developing and distributing the next generation of structured products. Through its special purpose vehicle Quantem LLC, the Company enables broker dealers to offer new private placement securities that provide for both fixed income and cryptocurrency solutions. The new DelphX securities will enable dealers and their qualified institutional investors (QIBs) accounts to competitively structure, sell and make markets in:

• Collateralized put options (CPOs) that provide secured rating downgrade protection for underlying corporate bonds and/or protection from losses in cryptocurrency holdings;

• Collateralized reference notes (CRNs) that enable investors to take on a capped rating downgrade and/or cryptocurrency loss exposure of an underlying security or cryptocurrency in exchange for attractive returns.

All CPOs and CRNs are fully collateralized and held in custody by US Bank. CPOs and CRNs are proprietary products created and owned by DelphX Capital Markets.

For more information about DelphX, please visit www.delphx.com

George Wentworth, General Manager
DelphX Capital Markets Inc.
george.wentworth@delphx.com

(718) 509-2160

Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.

FAQ

What did DelphX (DPXCF) announce about the unit private placement on Feb 25, 2026?

DelphX completed a non-brokered placement issuing 4,100,000 units for C$205,000. According to the company, each unit includes one common share plus a warrant exercisable at $0.08 for two years, with securities subject to TSXV approval and a four-month plus one-day hold.

How much did each DelphX (DPXCF) unit cost and what is included?

Each unit was priced at C$0.05 and includes one share and one warrant. According to the company, the warrant allows purchase of one common share at $0.08 for two years from issuance.

What are the exercise terms of the warrants issued by DelphX (DPXCF)?

Each warrant entitles the holder to buy one common share at $0.08 for two years. According to the company, warrants were issued with the units and will expire two years from the issuance date.

How does DelphX (DPXCF) plan to use the net proceeds from the offering?

DelphX intends to use the net proceeds for working capital and corporate overhead. According to the company, the funds are allocated to general corporate needs rather than a specific project or acquisition.

Are there conditions or restrictions on the securities from DelphX's (DPXCF) placement?

Yes. Closing is subject to TSX Venture Exchange approval and securities carry a four-month plus one-day hold period. According to the company, regulatory approval and the hold period apply to the issued units and warrants.